SL Science Holding SLBT
NASDAQ SLBT
$0.94 +0.04 (+4.16%)
As of: Nov 6, 2026 · 3:59 PM EST

SL Science Holding (SLBT) Cash & Equivalents (2024 - 2026)

Updated

SL Science Holding's Cash & Equivalents was $8.31 million in Q2 2026.

Analysis

SL Science Holding (SLBT) Cash & Equivalents (2024 - 2026) Analysis & Trends

At the end of FY2025, Cash & Equivalents at SL Science Holding came in at $1.26 million, down 65.8% from FY2024.

  • In earlier years, Cash & Equivalents was $3.68 million in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Eli Lilly 1,224.11 Bn 1,197.72 Bn 20.46 Bn 4.89 Bn
2 Johnson & Johnson 665.34 Bn 585.20 Bn 17.30 Bn 16.91 Bn
3 AbbVie 515.72 Bn 483.73 Bn 13.12 Bn 10.77 Bn
4 Merck 362.64 Bn 325.58 Bn 13.19 Bn 9.55 Bn
5 Novartis Ag 315.51 Bn 288.75 Bn - 400.00 Mn
6 Astrazeneca 289.26 Bn 263.15 Bn 13.26 Bn 7.94 Bn
7 Amgen 249.20 Bn 200.85 Bn 7.58 Bn 13.19 Bn
8 Gilead Sciences 207.48 Bn 182.59 Bn 6.73 Bn 6.44 Bn
9 Pfizer 167.49 Bn 114.85 Bn 12.56 Bn 1.82 Bn
10 SL Science Holding 1.98 Bn 1.96 Bn - 8.31 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 8.31 Mn
Mar 31, 2026 9,586.00
Dec 31, 2025 1.26 Mn
Dec 31, 2024 3.68 Mn
API Access

SL Science Holding Cash & Equivalents API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=SLBT&period=max&api_key=YOUR_API_KEY